Skip to main content

Advertisement

Log in

Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Introduction

Catheter-related bloodstream infections very often involve the premature removal of long-term intravascular devices (LTID). The antibiotic lock therapy (ALT) represents a conservative approach to the treatment of uncomplicated infections of tunneled LTID when catheter removal is not a feasible option.

Case report

We present here the first reported case of tunneled LTID bloodstream infection due to a multidrug resistant Lactobacillus rhamnosus. The patient, who had large granular lymphocytic leukemia, was successfully treated with systemic tigecycline therapy and lock therapy.

Conclusion

Our results confirm ALT as a valid catheter-salvage strategy for the treatment of CRBSIs in clinically stable patients when catheter removal is not a feasible option, tigecycline appear to be a good option.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.

    Article  PubMed  CAS  Google Scholar 

  2. O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME. Saint S; Healthcare Infection Control Practices Advisory Committee Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39:S1–34.

    Article  PubMed  Google Scholar 

  3. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007;7:645–57.

    Article  PubMed  Google Scholar 

  4. Segarra-Newnham M, Martin-Cooper EM. Antibiotic lock technique: a review of the literature. Ann Pharmacother. 2005;39:311–8.

    Article  PubMed  Google Scholar 

  5. Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J, García-San Miguel L, Moreno S. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother. 2006;58:816–21.

    Article  PubMed  Google Scholar 

  6. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother. 2005;55:90–4.

    Article  PubMed  CAS  Google Scholar 

  7. Guedon C, Nouvellon M, Lalaude O, Lerebours E. Efficacy of antibiotic-lock technique with teicoplanin in Staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. J Parenter Enteral Nutr. 2002;26:109–13.

    Article  CAS  Google Scholar 

  8. Cuntz D, Michaud L, Guimber D, Husson MO, Gottrand F, Turck D. Local antibiotic lock for the treatment of infections related to central catheters in parenteral nutrition in children. J Parenter Enteral Nutr. 2002;26:104–8.

    Article  CAS  Google Scholar 

  9. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother. 2003;47:3145–8.

    Article  PubMed  CAS  Google Scholar 

  10. Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Silvestri C, Licci A, De Fusco M, Provinciali M, Saba V, Scalise G. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother. 2005;49:4042–5.

    Article  PubMed  CAS  Google Scholar 

  11. Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother. 2007;51:78–83.

    Article  PubMed  CAS  Google Scholar 

  12. Aslam S, Trautner BW, Ramanathan V, Darouiche RO. Pilot trial of N-acetylcysteine and tigecycline as a catheter-lock solution for treatment of hemodialysis catheter-associated bacteremia. Infect Control Hosp Epidemiol. 2008;29:894–7.

    Article  PubMed  Google Scholar 

  13. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother. 2007;51:1656–60.

    Article  PubMed  CAS  Google Scholar 

  14. Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann Pharmacother. 2009;43:210–9.

    PubMed  CAS  Google Scholar 

  15. Wilson KH, Blitchington RB, Greene RC. Amplification of bacterial 16s ribosomal DNA with polymerase chain reaction. J Clin Microbiol. 1990;28:1942–6.

    PubMed  CAS  Google Scholar 

  16. Clinical and Laboratory Standards Institute: Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria: approved guideline. CLSI document M45-A. Clinical and Laboratory Standards Institute, Wayne; 2008.

  17. Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis. 2006;42:35–44.

    Article  Google Scholar 

  18. Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT. Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents. Antimicrob Agents Chemother. 2006;50:3507–13.

    Article  PubMed  CAS  Google Scholar 

  19. Aslam S, Trautner BW, Ramanathan V, Darouiche RO: Combination of Tigecycline and N-Acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother. 2007;51:1556–8.

    Article  PubMed  CAS  Google Scholar 

  20. Cafiso V, Bertuccio T, Spina D, Purrello S, Stefani S. Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus: comparison with other drugs. FEMS Immunol Med Microbiol. 2010;59:466–9.

    PubMed  CAS  Google Scholar 

  21. Messing B, Peitra-Cohen S, Debure A, et al. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 1988;12:185–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Bartalesi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bartalesi, F., Veloci, S., Baragli, F. et al. Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection. Infection 40, 331–334 (2012). https://doi.org/10.1007/s15010-011-0196-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-011-0196-3

Keywords

Navigation